developing long bones until birth. Long-bone-derived PaS cells and mSSCs are most prevalent in newborn mice, and molecular analysis shows that they constitute distinct progenitor populations from the earliest stages onward. Differential expression of CD90 and CD73 identifies four PaS subpopulations that display distinct chondro-and osteogenic differentiation potentials. Finally, we show that cartilage constructs generated from CD90 pos PaS cells are remodeled into bone organoids encompassing functional endothelial and hematopoietic compartments, which makes these cells suited for bone tissue engineering.
INTRODUCTION
A wealth of studies using bone-derived mesenchymal stromal cells (MSCs) has revealed their importance for engineering to repair cartilage and bone tissues, and for ameliorating hematopoietic disorders (Bianco, 2014) . However, it is still not firmly established whether MSC populations encompass mesenchymal progenitor and/or stem cells. In a recent review, Caplan (2017) proposes that MSCs, rather than being progenitor/stem cells, home to sites of injury and secrete factors that induce regeneration by resident stem cells. As it is indeed difficult to expand MSCs in culture without affecting their initial characteristics (Bianco, 2014; Mabuchi et al., 2013) , the prospective isolation and direct analysis of primary mesenchymal progenitors from human bone marrow and mouse long bones is central to identify their origins and assessing their multi-lineage differentiation potential. Since the first isolation of clonogenic mesenchymal progenitors from human bone marrow (Sacchetti et al., 2007) , lineage tracing and prospective characterization using mouse models has identified different types of mesenchymal progenitor/stem cells and provided fundamental insights into their functions during normal bone homeostasis and repair (Morrison and Scadden, 2014; Ono and Kronenberg, 2016) . However, the relatedness of these different mesenchymal populations from mice and their corresponding human orthologs remains uncertain.
Studying mouse limb development provides insight into the ontology and functions of the mesenchymal progenitors that orchestrate development of long bones (reviewed by Long and Ornitz, 2013) . In brief, the development of the skeletal primordia in early mouse limb buds is initiated by the condensation of multipotent mesenchymal progenitors at around embryonic day 10.5 (E10.5) and their commitment as Sox9-expressing osteo-chondrogenic progenitors (Akiyama et al., 2005) , which will form the cartilage primordia. The SOX9-positive cells differentiate into proliferating chondrocytes while peripheral mesenchymal cells will form the perichondrium (Akiyama and Lefebvre, 2011) . Endochondral ossification is initiated after chondrocytes become hypertrophic (E12.5), which involves differentiation of perichondrium progenitors into Osterix (Osx) expressing osteoblastic and mesenchymal progenitors Maes et al., 2010; Mizoguchi et al., 2014; Ono et al., 2014a) . Limb long bone growth and bone marrow formation depends on angiogenesis, which is triggered by vascular endothelial growth factor (VEGF)-mediated attraction of endothelial and hematopoietic progenitors (RE14.5; Morrison and Scadden, 2014) . The main migration of hematopoietic stem cells (HSCs) from the fetal liver to the bone marrow initiates perinatally, peaks immediately after birth, and continues until puberty, after which bone homeostasis is achieved (Kim et al., 2007; Trumpp et al., 2010) . Concurrently, the cellular composition of the mesenchymal stromal compartment changes to support hematopoiesis (Greenbaum et al., 2013; Maes et al., 2010; Mizoguchi et al., 2014) . Marking of Col2a expressing cells in mouse embryos at E13.5 shows that these cells are retained in the epiphysis and metaphysis of long bones for up to 1 year after birth (Ono et al., 2014b) . Marking Osx-expressing cells at E14.5 allows detection of labeled descendants in the diaphysis of even older mice , which is not the case if Osx-positive hypertrophic chondrocytes are marked one day earlier (E13.5; Maes et al., 2010; Ono et al., 2014a) . In addition to hypertrophic chondrocytes and early osteoblasts, Osx is expressed in mesenchymal progenitors of the developing bone marrow up to early postnatal stages (through postnatal day 3 [P3]; Mizoguchi et al., 2014; Ono et al., 2014b) . These and other studies suggest that there are different checkpoints during the endochondral ossification program that dictate the induction or reprogramming of new types of mesenchymal progenitors in situ or from nearby tissues.
Prospective isolation by flow cytometry detecting specific signatures of cell-surface molecules allowed identification of distinct mesenchymal and skeletal progenitor populations. Among these is a rare population of cells isolated by enzymatic digestion of compact bone and referred to as PaS cells (CD45  neg TER119 neg PDGFRa pos SCA-1 pos ; Morikawa et al., 2009) . PaS cells are quiescent cells located in the perivascular space close to the endosteum. They display the highest fibroblast colony-forming units (CFU-F) capacity among the different mesenchymal progenitor populations isolated from mice and possess a robust tri-lineage differentiation potential (Morikawa et al., 2009; Zhou et al., 2014a) . In mice, PaS cells give rise to osteoblasts, are able to maintain long-term HSCs, and home back to bone marrow following intravenous injection (Chan et al., 2009; Greenbaum et al., 2013; Hu et al., 2016; Morikawa et al., 2009; Park et al., 2012) . PaS cells express Mx1 but are not part of the cell populations marked in Col2a and Osx lineage-tracing experiments (Ono et al., 2014b; Park et al., 2012) . More recently, CD200 pos CD51
pos mesenchymal progenitors (lacking CD90, CD105, and 6C3) were isolated as a mesenchymal population able to give rise to cartilage and bone. These multipotent cells were termed mouse skeletal stem cells (mSSCs) and are able to support hematopoiesis in vivo (Chan et al., 2015) . Finally, analysis of bone marrow stromal cells from human fetuses identified a mesenchymal cell population expressing platelet-derived growth factor receptor a (PDGFRa) and CD51 (PaCD51 cells), which is also able to self-renew and support expansion of HSCs (Pinho et al., 2013) . As it is not clear when these different mesenchymal progenitor cells arise and to what extent they are ontogenetically related, we used their characteristic CD signatures for flow-cytometric analysis of the stromal compartment of limb buds and long bones from mouse embryonic and postnatal stages. We show that murine PaS cells and mSSCs, which arise among the PaCD51-positive mesenchymal cells in early limb buds, constitute two distinct cell populations in developing and adult long bones. PaS cells can be subdivided into four subpopulations using CD73 and CD90, which mark chondrogenic and osteogenic lineages, respectively (Chan et al., 2015; Chung et al., 2013; Ode et al., 2013; Wu et al., 2013) . PaS cells are already detected during formation of the cartilage anlagen in early limb buds and are most abundant in newborn mice. We also determined the bone-forming capacity of cartilage engineered from CD90 pos , CD90 neg and parental PaS cells following subcutaneous implantation. The CD90 pos PaS scaffolds are efficiently remodeled into bone organoids (for a definition of bone organoids see Bianco, 2014) , which contain a well-structured marrow consisting of mesenchymal progenitors and host-derived endothelial and hematopoietic compartments.
RESULTS

Ontogenic Identification and Relatedness of Limb Bud and Long Bone Mesenchymal Cell Populations with PaCD51 and PaS Signatures
Mouse limb buds and developing long bones were analyzed at different embryonic, fetal, and postnatal time points to 1D ). From E14.5 onward, the PaS population increases progressively ( Figure 1C ) such that the highest proportion is observed around birth (30% at E18.5 and P1-3, Figure 1B ). This analysis (Figure 1 ) establishes that the PaCD51-positive cells encompass the PaS population at all stages. This is relevant to potential therapeutic applications as, in contrast to CD51, the SCA-1 antigen is not present in humans (Lee et al., 2013) . To gain insight into the potential overlap of these two cell populations with Sox9-positive progenitors, we included the Sox9 IRES-GFP transgene in our analysis (Chan et al., 2011) . In early limb buds (E10.5), the Sox9-GFP-positive cells correspond mostly to osteo-chondroprogenitors (Akiyama et al., 2005 and our unpublished data). During subsequent development, Sox9 is expressed by chondroblasts, reduced in proliferating chondrocytes, and re-expressed in pre-hypertrophic chondrocytes (Akiyama et al., 2002; Dy et al., 2012) . While Sox9-GFP levels are always low in PaS cells, the majority of mSSCs express intermediate to high levels of Sox9 ( Figures 2C and 2D ).
As the Prx1-Cre transgene is expressed by most limb bud mesenchymal progenitors, we used it to activate a conditional GFP reporter (b-ACTIN-loxP-stop-loxP-EGFP; Jagle et al., 2007; Logan et al., 2002) . This allowed us to determine the fractions of PaCD51, PaS, and mSSC populations in GFP-positive cells at P2 ( Figure S1 ). This analysis revealed that all GFP-positive cells are contained in the PaCD51 population, which in turn shows that all PaS cells and mSSCs are GFP positive, i.e., are either Prx1-expressing cells or their descendants. In contrast the Pa cells, which become predominant during postnatal development, are GFP negative ( Figure S1 ). This analysis establishes PaCD51-positive cells as the major cell population within the mesenchymal (stromal) compartment during embryonic limb bud and fetal long bone development.
Next, the different mesenchymal populations in long bones after birth (P1-3) and during adult bone homeostasis (W10-13) ( Figure 3) were analyzed for the expression of key genes relevant to chondrogenesis, osteogenesis, and hematopoiesis (Prx1, Col2a1, and Mmp13; Osx, Lepr, and Cxcl12, respectively). qRT-PCR analysis of the different mesenchymal populations ( Figure 3A) showed that the different cell populations express distinct levels of these genes in a rather consistent manner when comparing newborn and adult mice. Per time point and cell type n R 3 independent experiments were analyzed. All results are presented as averages ± SD. Unpaired 2-tailed Student's t test was used to assess significance. *p < 0.05, **p < 0.01, ***p < 0.001 were considered statistically significant. points to the likely immature nature of PaS cells and is in agreement with their potential to support HSCs (see below). mSSCs isolated from adult long bones express high levels of Col2a1, Mmp13, and, notably, Osx (Figure 3C ), which corroborates their osteo-chondrogenic potential (Chan et al., 2015 (Greenbaum et al., 2013; Omatsu et al., 2010; Sugiyama et al., 2006) . Taken together, this analysis of few selected key genes corroborates the distinct nature Osx by pre-and hypertrophic chondrocytes, early osteoblasts, and MSC. Cxcl-12 and Lepr mark mesenchymal progenitors and MSC in the bone marrow. Expression levels are shown relative to the expression in PaCD51 cells. n R 4 independent experiments were analyzed per cell population. All results are presented as averages ± SD. Unpaired 2-tailed Student's t test was used to assess significance. *p % 0.05, **p % 0.01 were considered statistically significant.
of the different mesenchymal stromal progenitor populations identified by flow cytometry.
PaS Cells Are a Heterogeneous Population Consisting of Subpopulations with Distinct CD Signatures
The PaS population was analyzed in more detail, as these cells are detected from early limb bud stages onward (see above). We performed the same analysis as shown in Figures 1 and 2 but also assessing the expression of CD73 and CD90 (Figure 4 Figure 4A ). In vitro expansion of PaS cells causes a shift in the abundance of the four subpopulations. After two passages, the fractions of the two CD90 neg subpopulations are much reduced, while the CD90 pos PaS subpopulations become predominant ( Figure 4B ). This reduction is paralleled by a decrease in the multipotency, which affects mostly the osteo-chondrogenic differentiation potential (data not shown).
To understand when these four PaS subpopulations arise during limb long bone development, we analyzed Lin neg cells isolated from Sox9-GFP expressing embryos and mice by flow cytometry (Figure 5 ). During embryonic, fetal, and early postnatal stages, the Sox9-GFP-positive cells that mark the osteo-chondrogenic lineage ( Figure 5A The PaS progenitors are a heterogeneous population, as 10%-15% of them are also Sox9-GFP positive in early limb buds ( Figure 5D ). In fact, the majority of Sox9-GFPpositive progenitors in the stromal fraction correspond to osteo-chondrogenic progenitors that also express CD73 ( Figure S2B ). During the onset of endochondral ossification (E14.5-15.5), the four PaS subpopulations detected in adult long bones become apparent ( Figures 5C and 5F , compare The rightmost panels show averages ± SD for n R 8 independent experiments per dataset.
with Figure 4A ). Already at this early stage, PaS cells are detected in the developing perichondrium ( Figure S2C ). Around birth (E18.5 and P2), the CD90 neg CD73 hi PaS subpopulation is most abundant (Figures 5C and 5F ). From W4 onward, the two CD90 pos PaS subpopulations become most prominent as they increase to 75% of all PaS (Figures 5C and 5F). The maximum numbers of PaS cells can be isolated from mouse long bones at early postnatal stages (P1-4: 12-20 3 10 3 cells), while their numbers decrease progressively thereafter (%6.5 3 10 3 cells in adult mice, Figure 5G) . Furthermore, the fraction of Sox9-GFP-positive cells remains rather constant in all four PaS subpopulations during fetal long bone development, but increases to 70% by puberty around W4 ( Figure 5D ).
In Vitro Tri-lineage Differentiation Potential of the Four PaS Subpopulations As PaS cells are most prominent at P2 ( Figure 5G ) and the chondrogenic and osteogenic programs are both active, the four subpopulations were isolated from limb long bones to assess their in vitro clonogenic and tri-lineage differentiation potential ( Figures S3 and 6 ). Clonal analysis establishes that the clonogenic potential of the two CD90 pos subpopulations is 2-fold higher than one of the CD90 neg (ii) The peroxisome proliferator-activated receptor g (PPARg) protein distribution was analyzed by immunofluorescence. Lipid droplets were revealed by Nile red staining after 10 days of differentiation. Transcript levels were normalized to Rpl-19 transcripts. Nuclei were counterstained with DAPI (blue). n R 2 independent experiments were analyzed per data point and yielded identical results. Results in (i) are presented as averages ± SD. Scale bars, 100 mm. pos and CD90 neg PaS subpopulations were isolated from long bones of newborn mice. Following 1 week of expansion, the different cells were seeded into collagen type 1 (COL1) matrices and cultured for 1 week in chondrogenic differentiation medium (experimental samples) or expansion medium (controls). 3D cartilage constructs were analyzed for morphology (blue) and chondrogenesis by Safranin O (red staining), and the SOX9 (red) and COL2 (green) distribution determined by immunofluorescence. Scale bars, 100 mm. Figure S4 ).
(legend continued on next page)
PaS subpopulations ( Figure S3A ). However, cell clones derived from all four PaS subpopulations undergo proliferation arrest during in vitro expansion ( Figure S3B and data not shown), which precludes generation of sufficient cells for tri-lineage differentiation analysis. Therefore, equal numbers of freshly isolated cells from all four PaS subpopulations were only briefly expanded prior to inducing differentiation into chondrogenic, osteogenic, and adipogenic cells (tri-lineage differentiation, Figure 6 ; for details see Supplemental Experimental Procedures).
Culturing cells in chondrogenic differentiation medium results in upregulation of Sox9 and Col2a expression in all four PaS subpopulations ( Figure 6A ). However, the Sox9 and Col2a expression levels are much higher in the two CD90 ) is lower, but it is important to note that these cells are able to initiate both chondrogenic and adipogenic differentiation programs as revealed by transcriptional upregulation of specific markers for these lineages ( Figures  6A and 6C) . In osteogenic culture conditions, the Osx and seeded into collagen type 1 (COL1) matrices, and cultured in chondrogenic medium ( Figure 6A , see Experimental Procedures). After 1 week, the cartilage scaffolds generated by the three different cell populations were either analyzed ( Figure 7B ) or implanted subcutaneously into athymic nude mice ( Figure 7C ). Safranin O staining of matrices and detection of the SOX9 and COL2 proteins after 2 weeks showed that all three cell populations are able to produce cartilage in COL1 matrices ( Figure 7B ). In particular, it appears that the chondrogenic differentiation potential of CD90 pos PaS cells is significantly enhanced by culturing them in 3D COL1 matrices ( Figure 7B , compare with Figure 6Aii ). Eight weeks after subcutaneous implantation, the three types of scaffolds were explanted and histological analysis established that all cartilage tissues engineered from parental PaS cells and the CD90 pos PaS subpopulation had formed ossicles with bone marrow cavities (n = 5/5, Figure 7C ). In contrast, bone formation by CD90 neg PaSbased constructs is less efficient, as small ossicles with a poorly developed bone marrow compartment formed in only two of the five implants ( Figure 7C ). The absence of glycosaminoglycans (normally stained in red by Safranin O) establishes that the cartilage extracellular matrix was not maintained in vivo. Indeed, neither COL2 nor Aggrecan were detected in the remodeled explants (data not shown). As a significant fraction of PaS cells comprises SOX9-positive cells ( Figure 5D ), we analyzed the SOX9 distribution in the explants by immunofluorescence ( Figure S4 ). Few scattered SOX9-positive cells are present in explants derived from PaS cells and (D) Immunofluorescence analysis of the different constructs after 8 weeks in vivo differentiation to detect OSX-positive cells (red) and CD31-positive endothelial cells (green, indicative of angiogenesis). Sections were counterstained with DAPI (blue) to reveal nuclei. The enlarged regions 1 and 2 are shown in the right panels. Scale bars, 500 mm (low magnification) and 100 mm (high magnification).
(E) Immunofluorescence analysis of ossicles retrieved after implanting DsRed-positive CD90 pos PaS cartilage constructs (8 weeks). Left panels show that the CD45-positive hematopoietic cells are host derived, as they are not expressing DsRed. Right panels show that the CD31-positive endothelial cells are also host derived. Scale bars, 100 mm (upper panels) and 10 mm (middle and lower panels). (F) Sections through the bone marrow of CD90 pos PaS ossicles. Immunofluorescence analysis reveals Gr1-positive granulocytes and B220-positive cells (immature and mature B lymphocytes). Nuclei were counterstained with DAPI (blue). Scale bars, 100 mm (low magnification) and 10 mm (high magnification). (G) Co-localization of CD45 and SCA-1 (yellow) labels HSCs and multipotent progenitors. Co-expressing cells were observed near the endosteum (arrowhead in the left panel). Nuclei were stained with DAPI. Scale bars, 100 mm (low magnification) and 10 mm (high magnification). All results are representative of n R 3 independent samples.
CD90
pos PaS chondrogenic scaffolds, while abundant SOX9-positive cells remain in CD90 neg PaS explants (Figure S4) . In fact, this analysis showed that cartilage was not maintained in any of the constructs generated using the three different cell populations. This is likely due to the fact that the milieu of the host does not support cartilage maintenance, which depends on inhibition of VEGF signaling (Chan et al., 2015) . The distribution of CD31-positive endothelial and OSX-positive cells (Maes et al., 2010; Ono et al., 2014a) was analyzed on sections to gain insight into the extent to which the endochondral ossification had processed ( Figure 7D ). Cells expressing these markers are abundant in both PaS cells and CD90 pos PaS ossicles, but the distribution of CD31-positive and OSX-positive cells is much more organized in ossicles derived from CD90 pos PaS than in the ones using unfractionated PaS ( Figure 7D ). This correlates well with the larger and well-structured bone marrow compartment observed in CD90 pos PaS ossicles, which are reminiscent of bone organoids ( Figure 7C ). In contrast, fewer OSXpositive and no CD31-positive cells are detected in CD90 neg PaS explants ( Figure 7D ). These observations, together with the presence of a large number of SOX9-positive cells ( Figure S4 ), suggests that endochondral ossification was arrested at an early step during remodeling of CD90 pos PaS implants.
To determine whether the endothelial and OSX-positive cells were derived from implant or host, we isolated CD90 pos PaS cells from newborn mice expressing DsRed ubiquitously (Vintersten et al., 2004) and used them to generate cartilage constructs for implantation ( Figure 7A ). After 8 weeks, explants were analyzed by immunofluorescence. Donor-derived DsRed-positive cells are located in the compact bone and in the bone marrow in close contact with host-derived endothelial and hematopoietic cells ( Figure 7E ). In contrast, all hematopoietic (CD45) and endothelial (CD31) cells lack DsRed, which establishes that they are recruited from the host ( Figure 7E ). Further analysis of the hematopoietic compartment showed that CD45 pos cells encompass descendants of the common myeloid (granulocytes Gr1 pos ) and common lymphoid progenitors (immature and mature B cells detected by B220, Figure 7F ). Rare CD45 SCA-1 doublepositive cells are detected near the endosteum, which is indicative of multipotent hematopoietic progenitors (Seita and Weissman, 2010) . Our results establish that expanding PaS CD90 pos shortly in culture and differentiating them in 3D COL1 matrices results in cartilage constructs that are very efficiently remodeled into bone organoids in vivo ( Figure 7C ). In particular, the engrafted constructs attract host-derived endothelial cells to establish angiogenesis and generate a niche to recruit and maintain host-derived multipotent HSCs for hematopoiesis ( Figures 7D-7G ).
DISCUSSION
Flow-cytometric analysis was used to study the ontogeny of different mesenchymal progenitor populations during mouse limb and long bone development and homeostasis. We show that the majority of Lin neg mesenchymal cells during embryonic limb and fetal long bone are PaCD51 cells (Pinho et al., 2013) , while their numbers drop drastically after birth. A small fraction of Prx1-expressing PaCD51 cells persists into adulthood. This is in support of PaCD51 cells retaining progenitor characteristics. Most importantly, PaCD51 cells encompass at least three distinct cell populations: PaS cells (Morikawa et al., 2009) , CD200 pos cells that contain all mSSCs (Chan et al., 2015) , and at least one additional population, SCA-1 neg CD200 neg PaCD51 cells. These PaCD51DN cells express the highest levels of Cxcl12, which indicates that they might encompass/correspond to the adipo-osteogenic CAR progenitors needed for maturation of B lymphocytes (Greenbaum et al., 2013; Omatsu et al., 2010; Sugiyama et al., 2006) . This is in line with the recent observation that CAR cells are derived from the PaS population (Hu et al., 2016) and the fact that human PaCD51 cells isolated from fetal bone marrow are self-renewing, possess multilineage potential, and provide HSC niche functions (Pinho et al., 2013) . In addition, the different mesenchymal cell populations express Lepr, which is interesting as Lepr-positive mesenchymal progenitors are a main source of bone formed by adult bone marrow (Zhou et al., 2014a) . Others have proposed that the CD200 pos mSSCs are related to the progenitors that participate in endochondral bone formation during limb bud development, postnatal bone growth, and fracture healing (Cervantes-Diaz et al., 2016; Chan et al., 2015; Serafini et al., 2014; Yang et al., 2014; Zhou et al., 2014b Greenbaum et al., 2013; Morikawa et al., 2009; Ono et al., 2014b) . At this stage it is unclear whether the SCA-1 pos progenitors present in early mouse limb buds give rise to definitive PaS cells. We also show that PaS cells are not homogeneous, but consist of four subpopulations that become apparent during the onset of endochondral ossification. The highest numbers of PaS cells are detected perinatally and in newborn mice; coinciding with abundant chondrogenic and osteogenic activity, peak of endothelial cell numbers, and migration of fetal HSCs from liver to bone marrow (Ono et al., 2014a; Trumpp et al., 2010) . While all four subpopulations display CFU-F frequencies similar to that of the parental PaS population (Morikawa et al., 2009 ), they cannot be extensively expanded in culture (this study). In agreement with the major chondrogenic activity during embryonic and early postnatal long bone development, the two CD90 neg subpopulations represent the bulk of PaS cells during this period and possess the best tri-lineage differentiation potential in vitro. Therefore, it was unexpected that CD90 neg PaS cartilage constructs are not remodeled into bone organoids, but appear arrested at an early stage. This suggests that 3D cartilage constructs generated from CD90 neg PaS either lack osteogenic progenitors and/or that chondrogenesis did not progress to hypertrophy, which is necessary to trigger endochondral ossification (Long and Ornitz, 2013) . The ratio between CD90 neg and CD90 pos cells reverses in long bones around 2 weeks after birth as the CD90 pos PaS subpopulation becomes predominant. This switch occurs as the migration of HSCs is complete and bone marrow homeostasis is achieved (Trumpp et al., 2010) . CD90 pos PaS cells initiate, but do not complete tri-lineage differentiation in 2D culture, while seeding into 3D COL1 matrices results in efficient cartilage production. Most strikingly, CD90 pos PaS cells have the highest CFU-F potential in culture, and cartilage constructs derived from these cells are efficiently remodeled into bone organoids in vivo. These bone organoids contain a well-structured marrow with a host-derived hematopoietic and vascular system. In particular, donor-derived OSX pos cells resembling perinatal mesenchymal stromal progenitors Maes et al., 2010; Mizoguchi et al., 2014; Ono et al., 2014b) are present in proximity to host-derived endothelial and hematopoietic cells. Most importantly, rare CD45 pos SCA-1 pos cells are detected close to the endosteum, indicating that they correspond to short-term self-renewing HSCs. These findings agree with previous studies showing that PaS cells are required to maintain long-term self-renewing HSCs (Greenbaum et al., 2013; Hu et al., 2016; Morikawa et al., 2009) . Our study defines the emergence and relationships among the most relevant MSC-like populations in mice. In addition, we identify distinct PaS subpopulations and show that one of them, the CD90 pos PaS subpopulation, has the potential to differentiate into cartilage that is remodeled into bone organoids with a functional marrow in mice. As mouse PaS cells are contained within the PaCD51 population, our study could pave the way to identify the orthologous cells in humans, which may have important therapeutic implications for cartilage and bone tissue engineering and their co-transplantation with HSCs in human patients.
EXPERIMENTAL PROCEDURES
A detailed description of all procedures is included in Supplemental Experimental Procedures.
Mouse Strains
All studies using mice were performed strictly in adherence with Swiss law, the 3R principles, and the Basel Declaration. All animal studies were approved by the cantonal animal welfare and ethics committee (licenses no. 1951 to R.Z. and no. 1797 to I.M.). Personnel performing animal studies are trained and licensed according to FELASA standards. The persons performing surgery (subcutaneous implantation) have been specially trained. Unless indicated otherwise, mice of both sexes were used for analysis. The Prx1-Cre (Logan et al., 2002) , DsRed (mouse strain generated using DsRed.T3-expressing embryonic stem cells; Vintersten et al., 2004) , inducible b-Act-GFP (Jagle et al., 2007) , and Sox9 IRES-EGFP (Sox9-GFP, Chan et al., 2011 ) mouse strains were kept in a C57BL/6J genetic background. C57BL/6 and CD1 nude mice were purchased from Janvier and Charles River Laboratories, respectively.
Isolation of Mesenchymal Cells from Limb Buds and Long Bones for Flow-Cytometric Analysis
Cell suspensions were prepared from mouse embryonic limb buds and long bones for flow-cytometry analysis and sorting as described by Houlihan et al. (2012) . The modifications necessary to adapt the protocol to the different developmental stages analyzed are described in Supplemental Experimental Procedures.
Subcutaneous Engraftment of 3D Cartilage Scaffolds
PaS and CD90 pos and CD90 neg PaS subpopulations were sorted by flow cytometry from mouse hindlimb long bones at postnatal day 2 (P2) and expanded in vitro for 5-7 days under normoxic conditions (21% O 2 , 5% CO 2 ; Supplemental Experimental Procedures). Then 100,000 cells (20,000 cells/mL) were seeded per COL1-matrix (Avitene Ultrafoam Collagen Sponge; C.R. Bard, USA) and cultured in expansion medium overnight. Half of the matrices were continuously cultured in expansion medium to serve as controls, while the others were cultured in chondrogenic differentiation medium for 7 days (Supplemental Experimental Procedures). After this, one set of COL1-constructs per cell type was used for histological analysis by Von Kossa staining, Safranin O staining, and immunofluorescence. The others were subcutaneously implanted into adult nude CD1 mice (weeks 12-15) as previously described (Scotti et al., 2010) . Constructs were retrieved 8 weeks later and analyzed by histology and immunofluorescence (Supplemental Experimental Procedures and Scotti et al., 2013) . 
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